Ayala Marcelo, Chen Enping
Glaucoma Department, St Erik Eye Hospital, Karolinska Institutet, Stockholm, Sweden.
Clin Ophthalmol. 2011;5:573-6. doi: 10.2147/OPTH.S19873. Epub 2011 May 9.
Glaucoma is a progressive optic neuropathy that may lead to blindness. Reducing intraocular pressure (IOP) is the only known treatment to slow progression in glaucoma. IOP can be reduced by pharmaceutical treatment, laser and surgery. The aim of the present study was to assess predictive factors of success after selective laser trabeculoplasty (SLT) treatment.
We used a retrospective chart review of eyes that underwent SLT between January 1, 2005 and December 31, 2005. The dependent variable was time to failure after SLT treatment. Failure after SLT was defined as any changes in the medical treatment, and/or a new SLT treatment was performed and/or the patient was sent for surgery. All patients were treated with 90° SLT. A multivariate regression analysis was performed to assess correlation between time to failure after SLT and age, gender, IOP before treatment, number of medications used, SLT number, amount of spots, laser energy used, grade of angle, pigmentation and diagnosis.
120 eyes of 120 patients were identified. The average time to failure after SLT was 18 months. The predictive factors identified were: age, IOP before SLT and dose.
Predictive factors identified in our study were high baseline IOP, age and amount of laser energy used. Our study confirms previous results about baseline IOP as a predictive factor.
青光眼是一种可导致失明的进行性视神经病变。降低眼压(IOP)是已知的唯一能减缓青光眼病情进展的治疗方法。眼压可通过药物治疗、激光治疗和手术降低。本研究的目的是评估选择性激光小梁成形术(SLT)治疗后成功的预测因素。
我们对2005年1月1日至2005年12月31日期间接受SLT治疗的眼睛进行了回顾性病历审查。因变量是SLT治疗后至失败的时间。SLT治疗失败定义为医疗治疗有任何变化,和/或进行了新的SLT治疗,和/或患者被送去做手术。所有患者均接受90°SLT治疗。进行多因素回归分析以评估SLT治疗后至失败时间与年龄、性别、治疗前眼压、所用药物数量、SLT次数、光斑数量、所用激光能量、房角分级、色素沉着和诊断之间的相关性。
确定了120例患者的120只眼睛。SLT治疗后至失败的平均时间为18个月。确定的预测因素为:年龄、SLT治疗前的眼压和剂量。
我们研究中确定的预测因素为高基线眼压、年龄和所用激光能量。我们的研究证实了先前关于基线眼压作为预测因素的结果。